
|
Drug Product Approval Experts| The following experts are available as drug product approval consultants and drug product approval expert witnesses. Intota experts are peer-recommended authorities who have been carefully selected and rigorously screened. |  |
| | Definition: Drug Product Approval -
The approval of a drug, such as by the FDA, for distribution and sale. |
|
|
 | 1 to 25 (of 52) |  | | Drug Product Approval Experts |
|  | Request Free Expert Quote |  |  |  |  | Expert in FDA Compliance, Pharmaceutical New Products, Management Training, Seminars, Inspections, Audits During his employment with the Food and Drug Administration, Expert received five grade promotions, with his last position being that of Director of the Science Branch of the Philadelphia District. Expert's area of responsibility included all the ... See full profile |  | Georgia (GA), USA  |  |  |  |  |  | Expert in Pharmaceutical Formulation, Drug Delivery, CMC, NDA, and Formulation Patents Expert has developed multiple immediate release and modified release oral formulations at ALZA Corporation and at Transcept Pharmaceuticals. Many of these formulations have been commercialized including Invega (OROS paliperidone) and Exalgo (OROS ... See full profile |  | California (CA), USA  |  |  |  |  |  | Expert in Food & Drug Administration Rules, Policies, Procedures for Medical Devices and Pharmaceuticals Expert is an FDA compliance expert with 28 years experience in the field. He served the U.S. Food and Drug Administration as an Investigator concentrating in compliance for pharmaceuticals and medical devices as well as pre-market development of drugs and ... See full profile |  | Illinois (IL), USA  |  |  |  |  |  | Expert in Pharmaceutical/Biotech Clinical Trials, Regulatory, R&D, Mergers & Acquisitions, Trends, Outsourcing Expert is Director of Regulatory Affairs and Clinical Trials managing $3.6 billion at at a pharmaceutical company in New York, NY. His expertise is in managing and deploying outsource/insource teams worldwide for multiple clinical trials and ... See full profile |  | Michigan (MI), USA  |  |  |  |  |  | Expert in Drug Development (Small Molecules, Peptides, Biologics, Parenteral Nanoparticles); Drug Delivery Expert is an expert in analytical instrumentation and analytical methods development and validation, especially for drug regulatory filings with the FDA and EMEA according to all FDA and ICH guidelines. He established a state-of-art core instrument ... See full profile |  | Massachusetts (MA), USA  |  |  |  |  |  | Expert in Pharmaceutical Development, strategy planning and execution Expert graduated in Biology at the University of Utrecht, The Netherlands, in 1984. From 1985-89 he was a PhD student at the University of Basel. The research in the field of gene regulation was carried out at the Friedrich Miescher Institute (FMI; ... See full profile |  | Switzerland  |  |  |  |  |  | Expert in Regulatory Sub. NDS, ANDS, SANDS, NC, Cross References, Natural Health Products, Medical Devices Expert's firm has extensive expertise in regulatory submission. They provide different regulatory strategies to their customer's and prepare all types of submissions on their behalf. Expert also has extensive expertise in Narcotic's regulations. See full profile |  | Quebec, Canada  |  |  |  |  |  | Expert in Pharma/Biotech Development, Life-Cycle Management, 505(b)(2), Chemical Development, CRO Services Expert is a Pharmaceutical development leader with ~25 years drug development and manufacturing experience with large Pharma, large Biotech, and a highly successful small start-up. Managed large groups (from three different countries), teams and budgets. See full profile |  | Illinois (IL), USA  |  |  |  |  |  | Expert in Psychopharmacology in Historical Perspective, Regulatory Behavior, etc. Over the past 20 years he has done extensive research on the history of drug discovery, drug development, drug registration, and the use of psychopharmaceuticals in medical practice. Among the documents he has collected are the virtually complete set of ... See full profile |  | Wisconsin (WI), USA  |  |  |  |  |  | Expert in FDA Regulations, GMP/GLP/GCP Compliance; IND, NDA, BLA, PMA and Product Regulation; Toxicology Experienced in all aspects of validation and compliance including, GMP/GLP/GCP and part 11. Expert worked for over five years as a reviewer of investigational new drug applications, marketing applications, developing guidance and government policy and ... See full profile |  | California (CA), USA  |  |  |  |  |  | Expert in Clinical Trial and Drug Safety in New Drug Development and Marketing/Commercialization Expert has a working knowledge of ICH guidance related to patient protection and relevant US laws. As a prescribing physician and a physician in drug development for many years, Expert has expertise in drug mechanism of action and clinical data, and ... See full profile |  | New Jersey (NJ), USA  |  |  |  |  |  | Expert in Pharmaceutical Drug Development, Strategic Executive Management, Biopharma Mergers and Acquisitions Expert has over 20 years of experience. He is extensively active and has significant experience and expertise in Europe and the US in the areas of drug development and financing throughout Europe and the US. He was responsible for the overall ... See full profile |  | Netherlands  |  |  |  |  |  | Expert in Statistics and Data Management; Pharmaceutical Industry Expert has vast experience in the field of pharmaceutical development. He has been responsible for managing all quality laboratories, and product quality assessment and release to market. He has also evaluated process and product data for 54 drug ... See full profile |  | Illinois (IL), USA  |  |  |  |  |  | Expert in Gene Expression, Genomics, Microarrays, DNA, Drug Discovery, Product Development Expert has worked in the biotechnology industry for more than 24 years. He has directed R&D efforts in gene expression technology, genetic engineering technology, DNA microarrays, and high-throughput screening at Sandoz (Novartis), Operon, ... See full profile |  | California (CA), USA  |  |  |  |  |  | Expert in OTC, Generic, and New Drugs, Medical Device Regulations Expert now consults clients on matters pertaining to OTC drugs, generic drugs, new drugs and devices regulations and performs inspections of manufacturing facilities for compliance with current Good Manufacturing Practice Regulations. See full profile |  | Virginia (VA), USA  |  |  |  |  |  | Expert in Registration of Drugs, Medical Devices, Cosmetics,Borderline Products; Reimbursement, expert witness Expert has more than 30 years experience in the registration of ethical and OTC pharmaceuticals. He has worked with solid dosage forms, aerosols, sterile injectables, vaccines, topical products, and biotechnology products. See full profile |  | Oklahoma (OK), USA  |  |  |  |  |  | Expert in Pharmaceutical Product Development and Good Manufacturing Practices (cGMP, IQ/OQ, CMC, FDA, etc.) Expert is a consultant to the pharmaceutical and allied industries. His background includes 28 years with DuPont and DuPont Merck in a variety of positions. In his last assignment at DuPont Merck, he was Senior Director of Technology and Engineering in ... See full profile |  | New Mexico (NM), USA  |  |  |  |  |  | Expert in Pharmaceutical Quality Assurance, Quality Control, Supplier Selection and Supplier Quality Expert has extensive expertise in GMP matters in the pharmaceutical and medical device industries. During his 20 years in industry, he devised, managed and led programs to assure compliance to drug GMPs, GLPs and GCPs. See full profile |  | California (CA), USA  |  |  |  |  |  | Expert in Pharmaceuticals, Biotechnology, Clinical Pharmacology, Pharmacokinetics, Clinical Trials Expert is an expert in drug discovery and development years of experience in clinical pharmacology, pharmacokinetics and clinical trials of pharmaceuticals. Trained in medicinal chemistry, Expert undertook clinical pharmacology research in a ... See full profile |  | Victoria, Australia  |  |  |  |  |  | Expert in Biotech, Pharma and Medical Device Product and Process Development, Scale-up & Commercialization His approach to process validation is that PV begins at the process development phase. A process that is well understood, well defined as per the critical to quality attributes with an understanding of the variable interactions prior to the definition of ... See full profile |  | New Jersey (NJ), USA  |  |  |  |  |  | Expert in Regulatory Affairs, Technology Management, Pharmaceutical Industry, Turnaround Management Expert has experience in applying 21 CFR Part 11 to the manufacturing of pharmaceuticals and preparing and facing FDA inspections. He has more than 20 years of experience in various facets of API industry ranging from research to manufacturing, ... See full profile |  | Maharashtra, India  |  |  |  |  |  | Expert in Drug Delivery, Formulation Development of NCE's, Preformulation, Stability, Clinical Manufacturing She has been involved in contract manufacturing of pharmaceuticals for the drugs and devices. Contract manufacturing for drugs have included identification, evaluation, screening and selection of CRO's and CMO's in the area of sterile solution and oral ... See full profile |  | California (CA), USA  |  |  |  |  |  | Expert in Pharmaceutical Development, CMC, Project Management, Intellectual Property Expert has developed modified release products throughout his career. Most recently he led the development of proprietary oral modified release systems at Phoqus Pharmaceuticals. These included zero-order, increasing-rate, pulsatile, delayed-release, ... See full profile |  | Kent, United Kingdom  |  |  |  |  |  | Expert in FDA Litigation, Regulatory Compliance and Strategy & FDA Regulations Expert offers your company his 33 years of experience as an Attorney in the Office of the Chief Counsel of the FDA, and 8 years as a consultant to FDA-regulated industries. He provides clients with a wide-range of regulatory consulting services. See full profile |  | Virginia (VA), USA  |  |  |  |  |  | Expert in Hatch-Waxman patent litigation, CMC Pharma Dev Issues, Preformulation/Formulation, Regulat-Reports As the development of a pharmaceutical reaches Phase 3, prior to submission of an NDA, method validation is required. Validation is a demonstration of optimization. By demonstrating the capacity of a method within the bounds of validation, optimal ... See full profile |  | Florida (FL), USA  |  |  |  |  | >> Next 25 Experts
|
|
| |
|